Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural Killer/T-cell lymphoma in vivo and in vitro

被引:22
作者
Liu, Wen-jian [1 ,2 ]
Wang, Hua [1 ,2 ]
Peng, Xiong-wen [1 ,2 ]
Wang, Wei-Da [1 ,2 ]
Liu, Na-wei [1 ,2 ]
Wang, Yang [1 ,2 ]
Lu, Yue [1 ,2 ]
机构
[1] Collaborat Innovat Ctr Canc Med, Key Lab Oncol South China, Lab Hematol Oncologytate, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Hematol Oncol, 651 Dongfeng Dong Rd, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
asparagine synthetase; extranodal natural killer/T-cell lymphomax; asparaginase resistance; ACUTE LYMPHOBLASTIC-LEUKEMIA; INVOLVED-FIELD RADIATION; CANCER CELLS; RESISTANCE; APOPTOSIS; PROSTATE; THERAPY; TARGET; SMILE;
D O I
10.2147/OTT.S155930
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Although asparagine synthetase (AsnS) is associated with drug resistance in leukemia, its function in extranodal natural killer (NK)/T-cell lymphoma (ENKTL) remains unclear. Methods: The present study investigated the relationship between baseline AsnS mRNA levels and response to asparaginase in ENKTL cell lines. It also determined whether upregulating or downregulating the AsnS mRNA level induces or reverses asparaginase-resistant phenotype. Results: Interestingly, considerable differences were observed in the sensitivity to asparaginase of the five ENKTL cell lines. The AsnS expression levels were positively correlated with the IC50 values. In addition, the asparaginase resistance was induced or reversed by upregulating or downregulating the AsnS mRNA level in vivo and in vitro. Functional analyses indicated that AsnS did not affect the proliferation and apoptosis of ENKTL cells in the absence of asparaginase. Conclusion: Together, the data stress the importance of AsnS in the sensitivity to asparaginase in ENKTL and suggest a different therapeutic strategy for patients with a different level of AsnS expression.
引用
收藏
页码:6605 / 6615
页数:11
相关论文
共 31 条
[1]   Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype [J].
Ameri, K. ;
Luong, R. ;
Zhang, H. ;
Powell, A. A. ;
Montgomery, K. D. ;
Espinosa, I. ;
Bouley, D. M. ;
Harris, A. L. ;
Jeffrey, S. S. .
BRITISH JOURNAL OF CANCER, 2010, 102 (03) :561-569
[2]   Selective apoptosis of natural killer-cell tumours by L-asparaginase [J].
Ando, M ;
Sugimoto, K ;
Kitoh, T ;
Sasaki, M ;
Mukai, K ;
Ando, J ;
Egashira, M ;
Schuster, SM ;
Oshimi, K .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (06) :860-868
[3]   Up-regulation of asparagine synthetase expression is not linked to the clinical response to L-asparaginase in pediatric acute lymphoblastic leukemia [J].
Appel, Inge M. ;
den Boer, Monique L. ;
Meijerink, Jules P. P. ;
Veerman, Anjo J. P. ;
Reniers, Nathalie C. M. ;
Pieters, Rob .
BLOOD, 2006, 107 (11) :4244-4249
[4]   Asparagine synthetase expression alone is sufficient to induce L-asparaginase resistance in MOLT-4 human leukaemia cells [J].
Aslanian, AM ;
Fletcher, BS ;
Kilberg, MS .
BIOCHEMICAL JOURNAL, 2001, 357 :321-328
[5]   Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells [J].
Aslanian, AM ;
Kilberg, MS .
BIOCHEMICAL JOURNAL, 2001, 358 (358) :59-67
[6]   Asparaginases: A Successful Class of Drugs Against Leukemias and Lymphomas [J].
Avramis, Vassilios I. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (08) :573-579
[7]   L-ASPARAGINASE AND L-ASPARAGINE METABOLISM [J].
COONEY, DA ;
HANDSCHUMACHER, RE .
ANNUAL REVIEW OF PHARMACOLOGY, 1970, 10 :421-+
[8]   Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin [J].
Cui, Hongyan ;
Darmanin, Stephanie ;
Natsuisaka, Mitsuteru ;
Kondo, Takeshi ;
Asaka, Masahiro ;
Shindoh, Masanobu ;
Higashino, Fumihiro ;
Hamuro, Junji ;
Okada, Futoshi ;
Kobayashi, Masataka ;
Nakagawa, Koji ;
Koide, Hideyuki ;
Kobayashi, Masanobu .
CANCER RESEARCH, 2007, 67 (07) :3345-3355
[9]   TELAML1-positive ALL - A discordant genotype [J].
den Boer, ML ;
Evans, WE ;
Pieters, R .
CELL CYCLE, 2005, 4 (08) :997-998
[10]  
Fine BM, 2005, CANCER RES, V65, P291